“A Correct Diagnosis is Three-Fourths the Remedy” - Mahatma Gandhi
The First Lateral Flow Test designed for your Smartphone
Viscera Technologies brings laboratory-precision testing directly to patients through smartphone-powered lateral flow analysis. Our platform delivers quantitative results in minutes, not days, making professional-grade diagnostics accessible anywhere.
We combine our patented lateral flow technology with intelligent self-correcting algorithms—delivering laboratory precision anywhere, with any smartphone, enabling healthcare providers to make confident decisions at the point of care. From remote clinics to home monitoring, we're democratising access to the diagnostic accuracy that drives early intervention, allows for remote diagnosis and screening, and improves outcomes.
Diagnostics, Simplified.
Our Platform - Quantico
Quantico takes lateral flow testing to the next level, enabling quantitative, lab-quality results—without the lab. Using a smartphone-based reader, Quantico eliminates the need for dedicated hardware while maintaining precision and scalability.
Designed for clinical, home, and remote use, Quantico makes testing affordable, efficient, and accessible across a wide range of conditions. From early disease detection to monitoring and screening, it redefines how and where diagnostics can be delivered.
Precision Diagnostics - At Your Fingertips
Healthcare is often reactive, with diagnosis delayed by cost, accessibility, and infrastructure limitations. At Viscera Technologies, we believe in bringing diagnostics closer to the patient—making testing fast, seamless, and universally accessible.
Traditional lateral flow tests were designed for the human eye, not smartphone cameras. We've invented the first lateral flow technology specifically engineered for smartphone imaging, with self-correcting algorithms that eliminate environmental variables. This isn't an incremental improvement. It's a fundamental redesign that transforms any smartphone into a quantitative diagnostic device, able to make inroads to and potentially grow a market worth $45Bn. Our patented innovations are available for licensing or acquisition.
Timely diagnosis is the foundation of effective care. By removing barriers to testing, we empower individuals and healthcare providers with the insights needed to act earlier, preventing disease progression and reducing the burden on healthcare systems. Our mission is to reshape diagnostics for a future where early detection is the standard, not the exception.
News
Prix Galien Award 2025 nomination
We are excited to announce that Viscera Technologies has been nominated for the prestigious 2025 UK Prix Galien Award. The result will be revealed on June 5th - stay tuned for updates.
WHO Publishes Global strategy on digital health
The World Health Assembly through its resolution WHA58.28 on eHealth urged Member States “to consider drawing up a long-term strategic plan for developing and implementing eHealth services… to develop the infrastructure for information and communication technologies for health…to promote equitable, affordable and universal access to their benefits.”
Viscera team listed as a part of TechRound’s 29under29
Founders Henry and Ryan were named amongst the 29 recognised entrepreneurs in Techrounds’ prestigious 29under29. Click the link below for the full interview.